Inicio
Explorar
nav.journalClub
Tendencias
Más
synapse
⌘+K
Idioma
Español
Antiseizure medication discontinuation in pediatric epilepsy: Real-world insights | Synapse
March 3, 2026
Antiseizure medication discontinuation in pediatric epilepsy: Real-world insights
DM
Deniz Menderes
SA
Salih Akbaş
Antalya Eğitim ve Araştırma Hastanesi
ES
Esra Serdaroğlu
Ver todo
Puntos clave
Discontinuation of antiseizure medication may lead to varying clinical outcomes, affecting pediatric epilepsy management.
In the study of 200 pediatric patients, a 30% increase in seizure frequency was noted post-discontinuation within 6 months.
Analysis of real-world data on antiseizure medication discontinuation highlights the complexities in managing pediatric epilepsy.
Findings suggest a need for careful consideration of medication management strategies when discontinuing antiseizure treatments.
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Cite This Study
Copy
Menderes et al. (Wed,) studied this question.
synapsesocial.com/papers/69a75cbec6e9836116a25ddf
https://doi.org/https://doi.org/10.1016/j.eplepsyres.2026.107742